Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells 14,692 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CFO Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total value of $226,697.56. Following the completion of the transaction, the chief financial officer now directly owns 1,402,862 shares of the company's stock, valued at $21,646,160.66. This represents a 1.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Trading Up 1.9 %

Shares of Alignment Healthcare stock traded up $0.30 during midday trading on Monday, reaching $16.09. The company had a trading volume of 2,691,822 shares, compared to its average volume of 1,400,843. The firm has a market cap of $3.09 billion, a PE ratio of -20.90 and a beta of 1.49. The stock has a fifty day moving average price of $14.38 and a 200 day moving average price of $12.46. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $16.30.

Remove Ads

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently modified their holdings of the company. R Squared Ltd bought a new position in Alignment Healthcare during the fourth quarter worth $55,000. RiverPark Advisors LLC acquired a new stake in Alignment Healthcare during the 4th quarter worth about $106,000. Tower Research Capital LLC TRC raised its position in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after acquiring an additional 6,286 shares in the last quarter. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare in the 4th quarter worth about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Alignment Healthcare in the 3rd quarter valued at about $131,000. 86.19% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Barclays lifted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research report on Friday, February 28th. Piper Sandler upped their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a research report on Tuesday, March 4th. JPMorgan Chase & Co. raised their target price on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. Stephens reiterated an "overweight" rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Monday, February 24th. Finally, William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.